Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Molina Healthcare Inc

MOH

Molina Healthcare Inc

Molina Healthcare Inc historical holders

total: 6

Viking Global Investors Molina Healthcare Inc transactions over time

Total transactions:
24
New positions:
4
Sold out:
4
Added:
7
Reduced:
9
Held since:
2025 Q2
Held for:
1 quarter
Latest activity:
2025 Q3
Ole Andreas Halvorsen has been an institutional investor in Molina Healthcare Inc (MOH) since 2014 Q3. According to 2026 Q1 report, Ole Andreas Halvorsen doesn't hold any shares. The fund/company first acquired MOH in 2014 Q3, initially purchasing about 1.18M shares. Ole Andreas Halvorsen later completely sold out the position and reinvested in MOH again in 2025 Q2. Since the initial investment, Viking Global Investors has made 23 more transactions in this position.

When did Ole Andreas Halvorsen exit their MOH position?

Ole Andreas Halvorsen no longer holds Molina Healthcare Inc (MOH). They sold off their entire position in 2025 Q3, closing out an investment that began in 2014 Q3.

When did Ole Andreas Halvorsen first invest in MOH?

Ole Andreas Halvorsen first invested in Molina Healthcare Inc (MOH) in 2014 Q3 at the reported quarter-end price of $42.30 per share, acquiring 1,183,932 shares in their initial purchase.

What is Ole Andreas Halvorsen's average cost basis for MOH?

Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for Molina Healthcare Inc (MOH) is approximately $297.90 per share. This represents their average reported price* across all buy transactions.

Has Ole Andreas Halvorsen reinvested in MOH after selling?

Yes, Ole Andreas Halvorsen has shown renewed interest in Molina Healthcare Inc (MOH). After completely selling their position, they reinitiated an investment in 2025 Q2, demonstrating continued conviction in this ticker.

Estimated cost basis*

Weighted AVG buy price:
$297.90
Weighted AVG sell price:
$297.90

MOH transactions history by Viking Global Investors

24 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2025 Q3
0.00%
0
$297.90
-100% (-267,421)
-0.23%
2025 Q2
0.23%
267,421
$297.90
$79,664,716
new
+0.23%
2023 Q2
0.00%
0
$267.49
-100% (-594,553)
-0.75%
2023 Q1
0.75%
594,553
$267.49
$159,036,982
+1.08% (+6,345)
+0.01%
2022 Q4
0.97%
588,208
$330.22
$194,238,046
+44.64% (+181,537)
+0.3%
2022 Q3
0.62%
406,671
$329.84
$134,136,000
-14.41% (-68,487)
-0.1%
2022 Q2
0.61%
475,158
$279.61
$132,859,000
+13.98% (+58,275)
+0.07%
2022 Q1
0.56%
416,883
$333.59
$139,068,000
-6.88% (-30,803)
-0.03%
2021 Q4
0.41%
447,686
$318.08
$142,400,000
-52.13% (-487,540)
-0.43%
2021 Q3
0.70%
935,226
$271.31
$253,736,000
-3.92% (-38,130)
-0.03%
2021 Q2
0.75%
$253.06
-32.11% (-460,397)
2021 Q1
1.00%
$233.76
+40.19% (+411,014)
2020 Q4
0.60%
$212.68
-15.97% (-194,320)
2020 Q3
0.80%
$183.04
+20.06% (+203,391)
2020 Q2
0.78%
$177.98
-25.75% (-351,584)
2020 Q1
0.99%
$139.71
-40.95% (-946,671)
2019 Q4
1.47%
$135.69
+57.27% (+841,862)
2019 Q3
0.84%
$109.72
new
2018 Q1
0.00%
$76.68
-100% (-1,672,822)
2017 Q4
0.79%
$76.68
-14.09% (-274,385)
2017 Q3
0.87%
$68.76
+31.85% (+470,375)
2017 Q2
0.69%
$69.18
new
2014 Q4
0.00%
$42.30
-100% (-1,183,932)
2014 Q3
0.20%
$42.30
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.